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1  | INTRODUC TION
Preterm birth is associated with increased respiratory symptoms1,2 
and decreased lung function.3 However, whilst it is often stated that 
these adverse events result from birth at an early stage of lung de-
velopment4 and interventions such as mechanical ventilation, the 
underlying mechanisms for the respiratory deficits continuing into 
childhood and beyond remain uncertain. These deficits may be due to 
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Abstract
Background: Preterm- born survivors have increased respiratory symptoms and de-
creased lung function, but the nature of bronchial hyper- responsiveness (BHR) is un-
clear. We conducted a systematic review and meta- analysis for BHR in preterm- born 
survivors including those with and without chronic lung disease in infancy (CLD) 
comparing results to term- born subjects.
Methods: We searched eight databases up to December 2016. Included articles 
compared BHR in preterm- born and term- born subjects. Studies reporting BHR as 
decreases in forced expiratory volume in 1 second (FEV1) after provocation stimuli 
were included. The analysis used Review Manager V5.3.
Results: From 10 638 titles, 265 full articles were screened, and 28 included in a de-
scriptive analysis. Eighteen articles were included in a meta- analysis as they reported 
the proportion of subjects who had BHR. Pooled odds ratio (OR) estimates (95% 
confidence interval) for BHR comparing the preterm and term- born groups was 1.88 
(1.32, 2.66). The majority of the studies reported BHR after a methacholine challenge 
or an exercise test. Odds ratio was 1.89 (1.12, 3.19) after methacholine challenge and 
2.59 (1.50, 4.50) after an exercise test. Nine of fifteen articles reporting BHR in CLD 
subjects were included in a meta- analysis. Differences for BHR including for metha-
choline (OR 4.35; 2.36, 8.03) and exercise (OR 5.13; 1.82, 14.47) were greater in the 
CLD group compared to the term group.
Conclusions: Preterm- born subjects especially those who had CLD had increased 
rates of BHR to direct (methacholine) and indirect (exercise) stimuli compared to 
term- born subjects suggesting subgroups might benefit from anti- inflammatory or 
bronchodilator therapies.
K E Y W O R D S
asthma, bronchial hyper-responsiveness, bronchopulmonary dysplasia, chronic lung disease 
of prematurity, exercise, methacholine, prematurity
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long- standing structural consequences of preterm birth, as evidenced 
by smooth muscle extension into the smaller airways well beyond that 
observed in term- born infants, especially where the infant has been di-
agnosed with chronic lung disease of prematurity (chronic lung disease 
[CLD], also called bronchopulmonary dysplasia, BPD).5,6	Alternatively,	
there are limited data suggesting that an active pro- inflammatory neu-
trophilic status7 and oxidant process may be continuing.8
The nature of the airway narrowing observed in preterm- born 
children can be tested using pharmacological stimuli, for example di-
rectly acting on smooth muscle cells’ receptors or indirectly via the 
release of mediators by pro- inflammatory airway cells.9 This process 
of assessment of bronchial hyper- responsiveness (BHR) has been 
extensively used in asthma, although it is not as discriminatory as 
expected as many asymptomatic subjects may have increased BHR 
and those with the disease may not.10 Nevertheless, BHR by both 
direct (eg histamine, methacholine) and indirect (eg exercise, man-
nitol) means has been used in preterm- born survivors to try to elu-
cidate the potential mechanisms underlying the airway obstruction 
observed. The current data do not conclusively confirm that BHR is 
increased in preterm survivors; furthermore, it is even less clear if 
direct agents have greater or similar effects to indirect agents. Thus, 
we conducted a systematic review and meta- analysis to identify if:
1. BHR was increased after preterm birth when compared to 
term-born controls.
2. BHR was increased in preterm-born subjects who had CLD 
compared to term-born subject
3. Any	increase	in	BHR	was	due	to	responses	to	(a)	direct	or	(b)	
indirect stimuli.
2  | METHODS
We used methodologies and data from our three previous system-
atic reviews.3,11,12	As	data	for	BHR	are	often	not	reported	in	titles	or	
abstracts, we combined several approaches. We (a) re- ran the initial 
searches for articles reporting FEV1 in preterm- born subjects
3; (b) 
adapted the initial search strategies to include additional keywords 
relating to BHR and ran them in eight databases; and (c) searched ref-
erences in the included articles to identify additional papers report-
ing BHR in preterm- born subjects compared to term- born subjects 
(see Data S1 for protocol, search strategy, and data collection form). 
Eight	 databases	 were	 searched:	 EMBASE,	 Health	 Management	
Information Consortium (HMIC), MEDLINE, Medline in Process, 
Scopus,	OpenSIGLE,	CINAHL	and	Web	of	Science.	Ethical	approval	
was not required.
2.1 | Eligibility criteria
Studies on BHR in preterm- born subjects of any age, (adults and 
children), with or without CLD, and of any gender were included. 
Randomized and nonrandomized intervention studies, prospective and 
retrospective case- control studies, and prospective and retrospective 
cohort studies were included. Preterm defined as birth <37 weeks’ ges-
tation	and	term	as	birth	≥37	weeks’	gestation.	Studies	which	recruited	
on the basis of birthweight were included if they reported gestational 
age and all subjects in the study group were preterm and the control 
group were term- born, or the birthweight cut- off for the preterm 
group	was	<1501	g.	Authors’	definitions	of	CLD	and	what	constituted	
BHR, and all methods of assessing BHR were accepted. However, only 
studies reporting a change in FEV1 after a challenge were included. 
Studies in all languages from all countries were considered.
2.2 | Study selection
Searches	 were	 conducted	 in	 December	 2016	 and	 January	 2017.	
Two	reviewers	(SJK	and	HC)	independently	screened	each	reference	
title and available abstracts, using the inclusion criteria. Complete 
manuscripts were obtained for those that met the inclusion criteria 
as judged by either reviewer. The two reviewers then screened the 
full manuscripts against the inclusion criteria. Where there was disa-
greement, a third reviewer (SK) made the final decision.
2.3 | Data collection process
SJK	data	extracted	included	articles.	Authors	of	articles	were	con-
tacted, where possible, for further details if the information was 
not in a format which enabled data extraction for inclusion in the 
systematic review. Multiple articles from the same cohort were re-
viewed	by	SK	and	SJK,	and	the	article	reporting	the	most	complete	
data was included.
2.4 | Assessment of study quality and risk of bias
Study quality was assessed based on criteria from the Newcastle 
Ottawa criteria and the Cochrane risk of bias tool. The quality as-
sessment sheet is shown in the Data S1. Each study was scored for 
representativeness of the cohort, appropriate selection of the non-
exposed group, exposure ascertainment and demonstration that the 
outcome of interest was not present at the start of the study, out-
come	assessment	and	adequacy	of	follow-	up	by	SJK.	Minimum	score	
was six and maximum score was 20.
2.5 | Outcome measures
Number of subjects with BHR (given by a defined change in FEV1 
after BHR challenge) in the premature group and in the premature 
CLD subgroup, compared with a term control group.
2.6 | Analysis of results
A	formal	meta-	analysis	was	conducted	for	the	studies	which	reported	
the number of subjects in the (a) preterm (with and without CLD) and 
control groups, and (b) preterm group with CLD and a term control 
group who had a positive BHR result as defined by the authors of each 
manuscript. Both meta- analyses were further analysed by dividing the 
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subjects into the different methods of testing for BHR to separate out 
the effects of direct and indirect challenges. The results of all studies 
including those not in the meta- analyses are also presented descrip-
tively.	A	 sensitivity	 analysis	was	performed	 to	 investigate	 the	effect	
of year of birth of the preterm- born subjects on BHR by dividing the 
preterm- born subjects into two groups (a) born on or after 1990 and (b) 
born before 1990. Where the subjects were born over a range of years, 
a mid- point was used.
2.7 | Statistical analysis
Statistical analyses were performed using Review Manager (RevMan) 
version 5.3.13	After	 initial	 exploration	of	 the	data,	we	used	 random-	
effects meta- analyses to allow for heterogeneity. Heterogeneity was 
assessed using the I2 statistic produced by RevMan. The following were 
used as a rough guide I2 “0%- 40% might not be important; 30%- 60%: 
may represent moderate heterogeneity; 50%- 90%: may represent 
substantial heterogeneity; 75%- 100%: considerable heterogeneity”.14 
There was large heterogeneity between the articles, due to a range of 
methods to assess BHR, variable outcomes measures and range of ages 
and gestations studied over a number of years.
3  | RESULTS
3.1 | Studies selected and their characteristics
A	total	of	10	638	article	titles	were	identified	of	which	265	full	arti-
cles were screened for inclusion. Twenty- eight15-42 met the inclusion 
F IGURE  1 Study selection results
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criteria (Figure 1). For the two studies that overlapped24,26 the one 
reporting BHR as a proportion of responders26 was included in 
the meta- analyses. Detailed demographics of included articles are 
shown in Table E1 (Data S1), and a summary of the demographics 
for the direct and indirect methods of assessing BHR is shown in 
Table 1a and b, respectively.
Of the 28 articles reporting BHR:
1. 14 performed a methacholine challenge
2. 12 performed an exercise test
3. 1 performed a cold air challenge
4. 1 performed testing with hypertonic saline
Many of the articles studied preterm- born subjects where pre-
maturity was defined as being born at a gestation of <37 weeks,15,18-
21,23,29,34,37,39,40,42 but there was heterogeneity in the groups as articles 
also sometimes only included extremely (<28 weeks’ gestation) or 
very	 (≤32	weeks’	 gestation)17,24-28,31-33,35,36,41 or late (33 - 36 weeks’ 
gestation) preterm- born subjects.38	Although	the	majority	of	studies	
studied randomly selected preterm subjects or studied cohorts, one 
study included preterm infants with congenital diaphragmatic hernia 
(CDH), but the authors provided data to us to only include the preterm 
and term control infants excluding CDH.22 Sensitivity analyses remov-
ing that study from all analyses marginally increased the odds ratios 
in favour of the preterm groups. In most of the included studies, BHR 
was tested as part of wider ranges of lung function assessments.
3.2 | Risk of bias across studies
The quality scores ranged from 9 to 18 (median 14). The studies not 
included in the meta- analyses had similar quality scores to those in-
cluded in the meta- analyses. Included studies range from 11 to 16 
(median 14) and not- included studies range from 9 to 18 (median 
14.5).
3.3 | Study outcomes
3.3.1 | BHR in preterm group compared to term 
control group
Eighteen of the 28 included articles were included in a meta- analysis.
The results of the meta- analysis of the 18 articles are shown in 
Figure	2A;	 demographics	 are	 described	 in	 the	Data	 S1	 (Table	 E1).	
The pooled estimates of OR (95% CI) for BHR in the preterm group 
was 1.88 (1.32, 2.66) P = 0.01.
The results for subjects who had a methacholine (direct) chal-
lenge or who had an exercise test (indirect challenge) are reported 
in Figure 2B and C, respectively, and demographics are shown in 
Table E1 (Data S1). The pooled estimates of OR (95% CI) for BHR 
in the preterm group was 1.89 (1.12, 3.19) P = 0.009 for the eight 
articles reporting results after a methacholine challenge and 2.59 
(1.50, 4.50) P = 0.0007 for the eight articles reporting results after 
an exercise test.
OR were greater for studies where the preterm- born subjects 
were born on or after 1990 than studies where the preterm- born 
subjects were born before 1990.
3.3.2 | BHR in preterm group who had CLD in 
infancy compared to term control group
Fifteen of the 18 articles also compared BHR in preterm- born 
subjects who had CLD with term controls,17,18,21,24-27,29,31,33-37,41 
see Data S1 for demographics (Table E1). We performed a meta- 
analysis for nine of the 15 articles although the total number 
studied	was	small	(Figure	3A).	The	definitions	of	CLD	used	by	the	
authors’ of the nine articles are reported in Table E2 (Data S1). The 
pooled estimates of OR (95% CI) for BHR in the preterm group 
who had CLD was 4.54 (2.68, 7.69), P < 0.00001. The results for 
the subjects who had a methacholine challenge or who had an 
exercise test are reported in Figure 3B and C, respectively. The 
pooled estimates of OR (95% CI) for BHR in the preterm group 
who had CLD was 4.35 (2.36, 8.03), P < 0.00001 for the four ar-
ticles reporting results after a methacholine challenge and 5.13 
(1.82, 14.47), P = 0.002 for the five articles reporting results after 
an exercise test. It should be noted that one study used different 
definitions for the preterm (PC20<4 mg/mL) and CLD (PC20<1 mg/
mL) groups to define a positive BHR response.27
3.3.3 | Description of studies not included in the 
meta- analyses
Ten articles were not included in the meta- analysis.17,19,23-26,29,33,36,39,40 
Six articles reported BHR after a methacholine challenge,17,19,23-26,39 
and four articles reported after an exercise test.29,33,36,40 The studies 
are described in detail in the Data S1 (Table E1). In general, all stud-
ies for both methacholine and exercise reported increases in BHR 
but the results were not always significantly different from included 
term- born controls. However, comparisons between articles were 
difficult due to heterogeneity.
4  | DISCUSSION
The results of our systematic review and meta- analyses suggest 
preterm- born subjects have greater BHR compared to term- born 
subjects, and differences are greatest for subjects who had CLD. 
Furthermore, the commonest used direct agent, methacholine, and 
indirect method, exercise testing, both resulted in greater BHR in 
preterm- born survivors with and without CLD and preterm- born 
subjects with CLD compared to term controls. Of note was the va-
riety of different stimuli and outcome measures used, making com-
parisons difficult between studies.
Respiratory symptoms in school- age preterm- born children are 
often inappropriately labelled as asthma; however, the underlying 
mechanisms are likely to be different to those in asthma. Previous 
studies43 have suggested that studying BHR by both direct and 
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indirect means may help elucidate the underlying mechanisms and 
aid targeted therapy, for example anti- inflammatory or smooth 
muscle relaxants. However, despite the various methods used in 
the meta- analyses and descriptive analyses, the collated results 
strongly suggest that BHR is more prevalent in preterm- born group 
compared to term- born subjects, especially in those who had CLD—a 
finding similar to those with asthma.
As	different	mechanisms	may	potentially	be	 identified	using	
direct (assessing smooth muscle phenotypes and responses) and 
indirect methods (pathways of inflammatory mediators), to assess 
F IGURE  2 A,	Number	of	subjects	with	bronchial	hyper-	responsiveness	(BHR)	in	the	premature	group	compared	with	term	control	group.	
B, Number of subjects with BHR after a methacholine challenge in the premature group compared with term control group. C, Number of 
subjects with BHR after an exercise test in the premature group compared with term control group
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BHR,9 we classified the studies using direct and indirect means 
to assess BHR. This is an important distinction to make as there 
is a suggestion that BHR responses may be different in asthma 
and in lung disease of preterm- born children: Kim et al43 reported 
children with asthma responded to both methacholine and ade-
nosine	5′-	monophosphate	but	children	with	CLD	only	responded	
to the methacholine suggesting that continuing inflammation may 
not be a factor in preterm- born subjects. Methacholine is a direct 
method of assessing BHR by assessing bronchial smooth muscle 
response,	and	adenosine	5′-	monophosphate	is	an	indirect	method	
of assessing BHR by pathways of inflammatory mediator release 
from airway mast cells. Therefore, as children with CLD only re-
sponded to the direct method, not indirect methods, it is possible 
inflammation may not be a factor in BHR of the CLD subjects in 
the study by Kim et al. This is clearly contradictory to two studies 
which reported increased neutrophilic inflammation in induced 
sputum and increased oxidant activity in exhaled breath con-
densate from children with CLD.7,8 The results, however, are in 
agreement with reports of low exhaled nitric oxide in children 
with CLD.44
Interestingly, separating the data on whether a direct or in-
direct method was used showed that both methods resulted in 
increased BHR in preterm- born subjects including the CLD group 
despite smaller numbers available for inclusion. Historically, it has 
been shown at autopsy that airway smooth muscle is both thicker 
and extends further down the airways in preterm subjects especially 
those dying from CLD when compared to matched term controls.5,6 
However, what happens in the current cohorts of survivors can only 
be speculative. Our data suggest that preterm- born subjects have 
increased responses to direct stimuli suggesting that treatment with 
F IGURE  3 A,	Number	of	subjects	with	bronchial	hyper-	responsiveness	(BHR)	in	the	premature	group	who	had	chronic	lung	disease	(CLD)	
in infancy compared with term control group. B, Number of subjects with BHR after a methacholine challenge in the premature group who 
had CLD in infancy compared with term control group. C, Number of subjects with BHR after an exercise test in the premature group who 
had CLD in infancy compared with term control group
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bronchodilators may be successful. Our previous systematic review 
confirmed responses to single doses of bronchodilators but longer 
term studies of bronchodilators in this group are lacking.11 Currently, 
treatment is variable with individual clinicians forming their own 
opinions based on limited data. The situation is further complicated 
as the smooth muscle phenotype may initially respond to bron-
chodilators but there is speculation that these cells may develop a 
more fixed unresponsive myofibroblast phenotype which may not 
respond to bronchodilator treatment.45
Our data also showed that exercise also resulted in convincing 
differences between the preterm groups when compared to term 
controls. Two small studies show that (neutrophilic) airway inflam-
mation and oxidant injury may be continuing in childhood in preterm 
airway disease but replication of these studies in larger numbers is 
required.7,8 The evidence for the efficacy of inhaled corticosteroids 
in lung disease of preterm- born survivors is also limited, although, 
taken together with our data, there is a suggestion that subgroups 
of preterm- born subjects may benefit from inhaled corticosteroids, 
although they may not be effective if neutrophilic inflammation is 
confirmed. Role of targeting the leukotriene pathway is also poorly 
studied	 in	 preterm-	born	 children	 with	 lung	 disease.	 Appropriate	
studies to evaluate the efficacy of both bronchodilators and inhaled 
corticosteroids are urgently required.
The preterm group with and without CLD has increased BHR 
to both direct and indirect but we were not able to assess if both 
were present in the same individuals. Besides the study by Kim 
et al43 (who assessed BHR by auscultation and oximetry), the study 
by Nikolajev and colleagues of moderately preterm- born children 
(mean gestation of 35 weeks) reported overlap between exercise, 
methacholine and cold air challenges as well as with responses to 
bronchodilators.46 It is likely that preterm- born subjects have either 
structural abnormalities or airway inflammation or both, but the rel-
evant studies to confirm or refute either are currently lacking.
5  | LIMITATIONS
As	with	all	systematic	reviews,	we	were	limited	by	the	data	in	in-
cluded articles. The majority of articles examined BHR as part of 
a wider range of lung function tests, and there was disparity in 
the articles. Interpreting the results was complex as the articles 
reported a range of methods used to test BHR. Variable inclusion 
criteria and agents—both pharmacological and physiological—were 
used to assess and report BHR outcomes which included induction 
of wheeze, changes in spirometry and changes in oxygen satura-
tion. Even when a change in FEV1 was used, the definitions of a 
positive	 response	 varied.	A	 number	 of	 articles	were	 excluded	 as	
they not only defined BHR after testing with a provocative agent/
test, but they also included data on subjects with a low FEV1 who 
had responded to an inhaled bronchodilator. In addition, articles re-
porting BHR in preterm- born subjects without a term- born control 
group and articles with preterm and term- born subjects combined 
in the results were excluded. Variable criteria were used to define 
CLD in articles included in the meta- analyses. We ideally would 
have liked to further analysis the CLD group by dividing the group 
into two: (a) CLD defined as a requirement for supplemental oxy-
gen	at	≥28	postnatal	days	and	(b)	CLD	defined	as	a	requirement	for	
supplemental	oxygen	at	≥36	weeks	postmenstrual	age.	However,	
the small number of subjects in the articles with the later definition 
meant	this	was	not	possible.	Additionally,	the	subjects	were	born	
at a wide range of gestational ages over a number of decades when 
medical management has progressed—whether BHR is affected by 
the survival of the extremely preterm babies is unclear.
6  | CONCLUSIONS
This is the first comprehensive systematic review and meta- analysis 
which collated and reported the effect of preterm birth on later 
BHR. Suggesting an increased rate of BHR in preterm- born subjects 
compared to term- born subjects, differences were greatest for sub-
jects who had CLD. Both direct (methacholine challenge) and indi-
rect (exercise) challenges resulted in increased BHR suggesting that 
subgroups of preterm- born subjects could potentially benefit from 
anti- inflammatory and/or bronchodilator therapies.
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